American College of Cardiology

When low HDL means ‘no sweat’

Posted on: 16/04/2014 - 17:40

WASHINGTON– Low HDL cholesterol does not increase the risk of coronary heart disease when LDL cholesterol and triglyceride levels are normal, according to an analysis from the <link...

Field of Interest: Cardiology

Type: News Item

Life partner provides better heart failure outcomes

Posted on: 16/04/2014 - 17:20

WASHINGTON – Marital status plays an underappreciated role in heart failure prognosis. Indeed, having a life partner was independently associated with a 12% reduction in the risk of all-cause...

Field of Interest: Cardiology

Type: News Item

ACC/AHA cardiovascular risk equations get a thumbs-up

Posted on: 14/04/2014 - 14:15

WASHINGTON – The controversial cardiovascular risk estimator introduced in the current American College of Cardiology/American Heart Association risk-assessment guidelines demonstrated "moderate...

Field of Interest: Cardiology

Type: News Item

Off-label use of novel anticoagulants accelerates

Posted on: 10/04/2014 - 18:30

WASHINGTON – The off-label use of novel oral anticoagulants for stroke prevention in patients with valvular atrial fibrillation has climbed steeply since the drugs reached the marketplace, mirroring...

Field of Interest: Cardiology

Type: News Item

'Favorable signal' for secondary coronary prevention in STABILITY

Posted on: 08/04/2014 - 16:50

WASHINGTON – A novel pharmacologic approach to the prevention of ischemic events in patients with stable coronary heart disease failed to reduce the combined risk of cardiovascular death, acute...

Field of Interest: Cardiology

Type: News Item

VIDEO: PCSK9 inhibitors placed in perspective

Posted on: 07/04/2014 - 16:55

WASHINGTON – "We’re at the dawn of an era of biological therapeutics in cardiology," Dr. Peter Libby, chief of cardiovascular medicine at the Brigham and Women’s Hospital in Boston, told us...

Field of Interest: Cardiology

Type: News Item

VIDEO: Exploring SYMPLICITY’s failure, Part 2

Posted on: 04/04/2014 - 18:35

WASHINGTON – Far from being doomed after the failure SYMPLICITY HTN-3, renal denervation for refractory hypertension will continue to be explored. But it can’t go very far without finding a way to...

Field of Interest: Cardiology

Type: News Item

Apixaban provides larger medical cost savings than other NOACs

Posted on: 04/04/2014 - 14:45

WASHINGTON – Apixaban yields the great medical cost savings of the three novel oral anticoagulants available as alternatives to warfarin for stroke prevention in patients with nonvalvular atrial...

Field of Interest: Cardiology

Type: News Item

Bariatric surgery’s benefit persists in type 2 diabetes

Posted on: 01/04/2014 - 14:30

WASHINGTON – Bariatric surgery combined with intensive medical therapy had a significantly greater impact on glycemic control, compared with medical therapy alone, in a <link...

Field of Interest: Endocrinology

Type: News Item

Evolocumab betters ezetimibe for lowering LDL in statin-intolerant patients

Posted on: 31/03/2014 - 20:00

WASHINGTON – Evolocumab, an investigational fully human monoclonal antibody, was associated with markedly greater LDL cholesterol reductions than ezetimibe in a phase III clinical trial of...

Field of Interest: Cardiology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters